Decreased c-Abl activity in PC-3 and LNCaP prostate cancer cells overexpressing the early growth response-1 protein

Oncol Rep. 2014 Jan;31(1):422-7. doi: 10.3892/or.2013.2829. Epub 2013 Oct 31.

Abstract

Early growth response-1 (Egr-1) and the non-receptor protein tyrosine kinase (c-Abl) are 2 response genes that can act as regulators of cell growth and apoptosis in response to stress. Both Egr-1 and c-Abl regulate cell proliferation and survival in different types of cancer cells. To study the effect of overexpression of EGR-1 on the activity of c-Abl in prostate cancer cells, human PC-3 and LNCaP cells were transfected with a control vector or a vector containing the murine Egr-1 cDNA and assessed for the expression of the c-Abl gene. Cells overexpressing Egr-1 were studied with respect to apoptosis (Annexin V)/DEVDase activity, Egr-1/c-Abl activation (western blotting) and cell proliferation (MTT assay). The cells were exposed to tumor necrosis factor α (TNF-α), a known inductor of Egr-1, to c-Abl inhibitor STI-571 and to small interfering RNA (siRNA)-Egr-1, respectively. The results from our studies strongly suggest that overexpression of Egr-1 decreased c-Abl activity independent of endogenous Egr-1 inhibition by siRNA-Egr-1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / genetics
  • Benzamides / pharmacology
  • Cell Line, Tumor
  • Cell Proliferation
  • Cell Survival / genetics
  • Early Growth Response Protein 1 / biosynthesis
  • Early Growth Response Protein 1 / genetics*
  • Humans
  • Imatinib Mesylate
  • Male
  • Piperazines / pharmacology
  • Prostatic Neoplasms / genetics*
  • Protein Kinase Inhibitors / pharmacology
  • Proto-Oncogene Proteins c-abl / antagonists & inhibitors
  • Proto-Oncogene Proteins c-abl / biosynthesis
  • Proto-Oncogene Proteins c-abl / genetics*
  • Pyrimidines / pharmacology
  • RNA Interference
  • RNA, Small Interfering
  • Tumor Necrosis Factor-alpha / pharmacology

Substances

  • Benzamides
  • EGR1 protein, human
  • Early Growth Response Protein 1
  • Piperazines
  • Protein Kinase Inhibitors
  • Pyrimidines
  • RNA, Small Interfering
  • Tumor Necrosis Factor-alpha
  • Imatinib Mesylate
  • Proto-Oncogene Proteins c-abl